Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 83

Sort by

Sort Order Select

Journal Articles

Early Immune Reconstitution and Relapse-Related Characteristics in Acute Myeloid Leukemia Patients after Transplantation

Weiqian Dai, Sha Hao, Linjie Wu, Xueying Zhao, Fang Dong, Lisha Wang, Erlie Jiang, Tao Cheng

Blood (2024) 144 (Supplement 1): 7347.

https://doi.org/10.1182/blood-2024-209275

Published: 2024

Journal Articles

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Tingting Zhang, Li Liu, Xiaohui Zheng, Biao Shen, Ming Gong, Xin Liu, Gang Li, Ying Zhang, Wenbin Cao, Chen Liang, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 2828.

https://doi.org/10.1182/blood-2024-209406

Published: 2024

Journal Articles

A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment

Xiaodong Mo, He Huang, Feng Chen, Yi Luo, Jia Chen, Erlie Jiang, Yicheng Zhang, Linghui Xia, Chengwei Luo Luo, Xinchuan Chen, Nainong Li, Ming Jiang, Sujun Gao, Dongqin Yang, Qingli Zuo, Yimin Chen, Li Yao, Pan Liang, Depei Wu

Blood (2024) 144 (Supplement 1): 99.

https://doi.org/10.1182/blood-2024-193191

Published: 2024

Journal Articles

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Blood (2024) 144 (Supplement 1): 97.

https://doi.org/10.1182/blood-2024-204703

Published: 2024

Journal Articles

Safety and Efficacy Results of Dose-Adjusted Inotuzumab Ozogamicin in Adults with B Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Experience

Erlie Jiang, Mengnan Lv, Yigeng Cao

Blood (2024) 144 (Supplement 1): 1422.

https://doi.org/10.1182/blood-2024-204581

Published: 2024

Journal Articles

The Role of Total Body Irradiation in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma: A Multicenter Retrospective Study in China

Hongye Gao, Jiali Wang, Zhuoxin Zhang, Hao Zhang, Xin Du, Yao Liu, Dehui Zou, Xianmin Song, Erlie Jiang

Blood (2024) 144 (Supplement 1): 4867.

https://doi.org/10.1182/blood-2024-205416

Published: 2024

Journal Articles

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Wang Ying, Jianxiang Wang, Weihua Zhai, Erlie Jiang

Blood (2024) 144 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2024-202404

Published: 2024

Journal Articles

Efficacy and Safety of a Modified Conditioning Regimen Based on Mitoxantrone Hydrochloride Liposome and Busulfan/Cyclophosphamide for Patients with Refractory and Relapsed Acute Myeloid Leukemia

Chen Liang, Donglin Yang, Yi He, Aiming Pang, Xiaohui Zheng, Gang Li, Mingzhe Han, Erlie Jiang, Sizhou Feng

Blood (2024) 144 (Supplement 1): 2127.

https://doi.org/10.1182/blood-2024-205285

Published: 2024

Journal Articles

Letermovir for Prevention of Cytomegalovirus Infection in Chinese Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Phase 3, Open-Label, Single-Arm Trial

Yun He, Lanping Xu, Yujun Dong, Xianmin Song, Yicheng Zhang, Erlie Jiang, Hu Yu, Ren Lin, Ying Wang, Xiaodan Guo, Weiwei Zhao, Cyrus Badshah

Blood (2024) 144 (Supplement 1): 7302.

https://doi.org/10.1182/blood-2024-199269

Published: 2024

Journal Articles

Selinexor Combined with Reduce Intensity Conditioning of BU/CY for Allogeneic HSCT in Elderly Patients with Relapsed/Refractory AML/MDS

Xiaofei Ni, Rongli Zhang, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7310.

https://doi.org/10.1182/blood-2024-203374

Published: 2024

Journal Articles

Elevated Dosing of Recombinant Human Thrombopoietin Accelerates Platelet Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Dosage-Optimization, Controlled Clinical Study

Dan Feng, Qingzhen Liu, Qiaoling MA, Erlie Jiang

Blood (2024) 144 (Supplement 1): 266.

https://doi.org/10.1182/blood-2024-200637

Published: 2024

Journal Articles

Autologous hematopoietic stem cell transplantation may overcome the adverse impact of IKZF1 on the prognosis of B-ALL in CR1 with no detectable minimal residual disease

Jiali Wang, Xiaoxiao Ma, Rongli Zhang, Erlie Jiang

Blood (2024) 144 (Supplement 1): 5897.

https://doi.org/10.1182/blood-2024-203058

Published: 2024

Journal Articles

Development and Evaluation of a Risk Predictive Model for High Level of Self-Reported Symptom Cluster Distress in Patients with Hematologic Malignancies

Zhang Qianqian, Jinying Zhao, Yating Liu, Zhen Song, Bo Jiang, Zhijian Xiao, Erlie Jiang, Wenjun Xie

Blood (2024) 144 (Supplement 1): 7911.

https://doi.org/10.1182/blood-2024-206411

Published: 2024

Journal Articles

Efficacy and Safety of Isavuconazole in the Treatment of Invasive Fungal Disease in Patients with Hematological Disorders

Nan Yang, Pan Pan, Aiming Pang, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7329.

https://doi.org/10.1182/blood-2024-210114

Published: 2024

Journal Articles

Divergent Prognostic Factors in High-Risk Vs. Standard-Risk Elderly Patients after Allo-HCT for AML/MDS

Wenwen Guo, Yigeng Cao, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7382.

https://doi.org/10.1182/blood-2024-202470

Published: 2024

Journal Articles

Clinical Observation of Sequential Prophylaxis with Letermovir Injection and Tablets for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Aiming Pang, Yawei Zheng, Shulian Chen, Yuyan Shen, Xiaoli Zhao, Xiaofei Ni, Lining Zhang, Jiali Wang, Wenbin Cao, Xin Chen, Yigeng Cao, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7292.

https://doi.org/10.1182/blood-2024-207795

Published: 2024

Journal Articles

Daratumumab for Treatment of Epstein-Barr Virus-Associated Post -Transplant Lymphocyte Proliferative Disease after Rituximab Treatment Failure

Gang Li, Donglin Yang, Sizhou Feng, Erlie Jiang, Xin Liu, Chen Liang, Yi He

Blood (2024) 144 (Supplement 1): 7391.

https://doi.org/10.1182/blood-2024-207492

Published: 2024

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Dewan Zhao, Wenbin Cao, Gang Li, Ying Zhang, Xiaohui Zheng, Xin Chen, Weihua Zhai, Qiaoling MA, Rongli Zhang, Jialin Wei, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2024-205145

Published: 2024

Journal Articles

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

Xiaoyu Zhang, Weihua Zhai, Qiaoling MA, Sizhou Feng, Yi He, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7366.

https://doi.org/10.1182/blood-2024-207353

Published: 2024

Journal Articles

Multi-Omics and Machine Learning Predict the Risk of Acute Graft Versus Host Disease

Ruixin Li, Jinting Fan, Mingming Niu, Haixiao Zhang, Hong Wang, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7364.

https://doi.org/10.1182/blood-2024-206987

Published: 2024

NARROW

Early Immune Reconstitution and Relapse-Related Characteristics in Acute Myeloid Leukemia Patients after Transplantation

Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Safety and Efficacy Results of Dose-Adjusted Inotuzumab Ozogamicin in Adults with B Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Experience

The Role of Total Body Irradiation in Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma: A Multicenter Retrospective Study in China

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Efficacy and Safety of a Modified Conditioning Regimen Based on Mitoxantrone Hydrochloride Liposome and Busulfan/Cyclophosphamide for Patients with Refractory and Relapsed Acute Myeloid Leukemia

Letermovir for Prevention of Cytomegalovirus Infection in Chinese Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Phase 3, Open-Label, Single-Arm Trial

Selinexor Combined with Reduce Intensity Conditioning of BU/CY for Allogeneic HSCT in Elderly Patients with Relapsed/Refractory AML/MDS

Elevated Dosing of Recombinant Human Thrombopoietin Accelerates Platelet Engraftment in Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Dosage-Optimization, Controlled Clinical Study

Autologous hematopoietic stem cell transplantation may overcome the adverse impact of IKZF1 on the prognosis of B-ALL in CR1 with no detectable minimal residual disease

Development and Evaluation of a Risk Predictive Model for High Level of Self-Reported Symptom Cluster Distress in Patients with Hematologic Malignancies

Efficacy and Safety of Isavuconazole in the Treatment of Invasive Fungal Disease in Patients with Hematological Disorders

Divergent Prognostic Factors in High-Risk Vs. Standard-Risk Elderly Patients after Allo-HCT for AML/MDS

Clinical Observation of Sequential Prophylaxis with Letermovir Injection and Tablets for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Daratumumab for Treatment of Epstein-Barr Virus-Associated Post -Transplant Lymphocyte Proliferative Disease after Rituximab Treatment Failure

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Humanized Anti-CD25 Monoclonal Antibody for Graft-Versus-Host Disease Prophylaxis in Older Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation

Multi-Omics and Machine Learning Predict the Risk of Acute Graft Versus Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only